baber/WOPTO huggingface dataset:
Patent EP-1634586-A1 (EP)
Inventor: CAEIRO RAMALHO MARIA JULIA
IPC: A61K9/20
Filed: 2004-09-09
Abstract: The present invention relates to fast water-dispersible tablets containing domperidone for oral administration. The formulations comprise domperidone or pharmaceutically acceptable salts thereof, about 60 - 80% of a "auxiliary" granulate (w/w), and about 10 - 30% of microcrystalline cellulose (w/w), expressed in relation to the total weight of the tablets, a sweetener, a flavouring agent and a lubricant obtained by wet granulation of D-mannitol and maize starch gum in a high shear granulator, it facilitates the flowability and the compressibility of the mixture and, because of its high solubility in water, contributes to the fast dispersion of the tablet. The formulations have an enhanced structural integrity, for instance having a friability lower than 1.0% and hardness values between 3 and 6 Kp, and are able to disperse in water within 3 minutes, preferably within 2 minutes and most preferably within 1 minute, to provide a dispersion that passes through a 710 µm diameter mesh size sieve and presents a pleasant taste and the absence of perceptible granules in the mouth. This invention also refers to the process for the preparation of said pharmaceutical preparations.
Patent EP-1529621-A1 (EP)
Inventor: HOFSTAETTER WILHELM
IPC: B29C49/78
Filed: 2004-10-29
Abstract: The outer contour of a preform to be heated is determined by feelers when it is inserted in an opening. Individually controlled heaters are then brought into action or withdrawn accordingly. Reflectors can also be moved into the required position, especially along the length of the preform. An independent claim is also included for the corresponding equipment with bow-shaped motor-driven feelers that are linked to the heater controls. The reflector has an angled bottom end to ensure uniform heating.
Patent EP-1592619-A1 (EP)
Inventor: MATHESON NORMA CATHERINE
IPC: B65D39/00
Filed: 2004-01-06
Abstract: La présente invention concerne un bouchon de contenant comprenant un corps (1) composé de matériau compressible et comportant au moins une extrémité destinée à être introduite dans une ouverture d'un contenant, ainsi qu'un revêtement pelliculaire (F) appliqué sur au moins une partie de cette extrémité du corps (1) de matériau compressible et constituant une barrière de protection entre le matériau compressible et les contenus du contenant, ladite extrémité du corps (1) du bouchon présentant une surface (2, 4, 5) à orientation axiale de forme irrégulière.
Patent EP-1587538-A1 (EP)
Title: Vaccins contre le meningocoque administres par la muqueuse
Inventor: DEL GIUDICE GIUSEPPE
IPC: A61K39/39
Filed: 2004-01-30
Abstract: L'invention concerne des compositions immunogènes en vue d'une administration muqueuse comprenant des sacharrides capsulaires provenant au moins de deux des sérogroupes A, C, W135 et Y de N.meningitidis. Les sacharrides capsulaires contenus dans les compositions de cette invention sont, de préférence, conjugués à une (des) protéine(s) porteuse(s) et/ou sont des oligosaccharides. On retient de préférence des antigènes d'oligosaccharides conjugués. L'invention concerne également des compositions immunogènes comprenant (a) un antigène de saccharide capsulaire provenant du sérogroupe C de N.meningitidis, et (b) un adjuvant de chitosane. La composition renferme de préférence (c) un ou plusieurs antigènes et/ou des un ou plusieurs adjuvants. Les compositions se prêtent particulièrement à une administration muqueuse, y compris l'administration intranasale. L'utilisation de chitosane et/ou d'adjuvants de toxines détoxifiés de ribosylation ADP améliore les réponses immunes muqueuses anti-méningocoque et permet la déformation des réponse Th1/Th2.
Patent EP-1718213-A1 (EP)
Inventor: THOMMEN DANIEL
IPC: A61B17/12
Filed: 2004-02-04
Abstract: An implant for occluding a passage in a circulatory system of a human body comprises elongate members (1) which can be twisted into fixation structures and at least two occluding bodies (2, 2′) being attached to the elongate members (1) and being arranged at a distance to each other. This implant combines the advantages of a single occluding body implant with the advantages of a double occluding body implant.
Patent EP-1604406-A1 (EP)
Inventor: ROCA I CABARROCAS PERE
IPC: H01L29/786
Filed: 2004-02-06
Abstract: The invention concerns a transistor for active matrix display and a method for producing the said transistor (1). The transistor (1) comprises a microcrystalline silicon film (5) and an insulator (3). The crystalline fraction of the said microcrystalline silicon film (5) is above 80%. According to the invention, the transistor (1) comprises a plasma treated interface (4) located between the insulator (3) and the microcrystalline silicon film (5) so that the said transistor (1) has a linear mobility equal or superior to 1.5 cm2V-1s-1, shows threshold voltage stability and wherein the microcrystalline silicon film (5) comprises grains (6) whose size ranges between 10 nm and 400 nm. The invention concerns as well a display unit having a line-column matrix of pixels that are actively addressed, each pixel comprising at least a transistor as described above.
Patent EP-1597450-A1 (EP)
Inventor: LITTLE ANTHONY RUSSELL
IPC: E05B65/20
Filed: 2004-02-24
Abstract: An access control system for controlling access to a restricted area or space using proximity detection of a portable control unit has a manually operated switch (18) that operates in conjunction with the proximity detection. When a control unit is sensed within range of a detection means, the switch is enabled so that subsequent actuation facilitates entry to the area or space. The space may be the interior of a vehicle, and the access control is a door (20) with a handle (12), movement of which in a defined direction operates the switch (18) to allow the door (20) to be opened by the handle (12). The switch (18) can also be used to lock the door (12).
Patent EP-1608918-A1 (EP)
Inventor: HELMINGER MARKUS
IPC: F24H9/20
Filed: 2004-03-11
Abstract: Bei einem Durchlauferhitzer (D) mit einem wenigstens eine Heizkörperanordnung (K, K1, K2) enthaltenden Heizmodul (H), einem drehbaren Stellglied (L) zur Heizleistungsvorwahl, wenigstens einem stationären elektrischen Schaltsystem (S), und einem durchflussabhängig linear verstellbaren Kulissensystem (A) zum Betätigen des Schaltsystems (S) ist das Kulissensystem (A) drehbar und mit dem Stellglied (L) gekoppelt, ist ein Schaltsystem (S) mit nur einem Schaltglied (3, 4, 3') pro Heizkörperanordnung vorgesehen, und ist das Kulissensystem (A) so ausgebildet, dass nur durch Einstellen der Drehposition des Kulissensystems (A) relativ zum Schaltsystem (S) die jeweilige Heizleistung vorwählbar und durch die lineare Verstellung des Kulissensystems abrufbar ist.
Patent EP-1728789-A1 (EP)
Inventor: OMURA SATOSHI
IPC: A61P33/00
Filed: 2004-03-24
Abstract: The present invention is comprised of culturing a microorganism belonging to fungi and having ability to produce antibiotic FKI-1778A and/or antibiotic FKI-1778B and/or antibiotic FKI-1778C and/or antibiotic FKI-1778D, accumulating the antibiotic FKI-1778A and/or antibiotic FKI-1778B and/or antibiotic FKI-1778C and/or antibiotic FKI-1778D in the cultured mass and isolating the antibiotic FKI-1778A and/or antibiotic FKI-1778B and/or antibiotic FKI-1778C and/or antibiotic FKI-1778D from said cultured mass. The thus obtained substance is expected as pharmaceuticals, animal drugs and agricultural chemicals, or as pharmaceuticals having growth inhibitory activities against cancer cells.
Patent EP-1629186-A1 (EP)
Inventor: ROESEL GERD
IPC: F02D41/14
Filed: 2004-04-22
Abstract: Summation by means of NI individual values occurs in blocks and begins prior to signal actualisation in order to determine the continuously probed individual values of the measuring signal by totalling the summation time corresponding to the rotationally dependent periods (TPl, TP2) of pressure pulsations of waste gas and by protecting the stored resources, such that in order to calculate an average value, the individual value for the actualisation time point (tn) is already embodied in a continuously blocked manner and intermediately stored block values are taken into account in place of the respective individual values.
Patent EP-1618843-A1 (EP)
Inventor: TAKIZAWA MASAHIRO
IPC: A61B5/055
Filed: 2004-04-23
Abstract: High-speed imaging by a propeller MRI method is enabled as a whole thanks to high-speed computation by preventing an aliasing artifact even if the echoes acquired by one blade are decreased and by reducing the imaging time and the computational complexity. In a magnetic resonance imaging apparatus, an RF pulse is applied to a subject placed in a static magnetic field, a plurality of gradient magnetic fields are applied, and induced nuclear magnetic resonance signal (echo signal) is received by means of a multiple RF receiving coil unit composed of two or more RF receiving coils. 
     A parallel MRI method is applied to echo signals acquired by reducing the echoes per blade of a propeller MRI method so as to remove the artifact to produce a reconstructed image. The reconstructed image is subjected to inverse Fourier transform to return it to the echo signals in a measurement space corresponding to the blade. 
     The echo signals are girded in an arbitrarily predetermined coordinate system for image and combined. 
     Such a processing is conducted for the echo signals of all the blades. A final image is reconstructed using the echo signals after the image creation in the coordinate system for image.
Patent EP-1618105-A1 (EP)
Inventor: DAVIDSON JAMES EDWARD PAUL
IPC: C07D409/12
Filed: 2004-04-29
Abstract: La présente invention concerne des composés représentés par la formule (I), certains de leurs sels ou promédicaments pharmaceutiquement admis, pour le traitement d'un trouble imputable à la médiation de récepteurs de CB1. Dans cette formule, R1 est aryle ou hétéroaryle. R2 est alkyle, aryle ou hétéroaryle. R3 est alkyle, aryle, hétéroaryle, NR9R10, OR15, ou NR16C(O)R17. Y est C=O, C=S, SO2, ou (CR7R8)p. Le 'm' = 1 ou 2. Le 'n' = 1 ou 2. Enfin, p=1, 2, 3 ou 4. Les R7 à R17 sont tels que définis dans les spécifications. En outre, si -Y-R3 est -C(O)NH(alkyle), R1 et/ou R2 sont choisis parmi les hétéroaryles, et/ou m et/ou n vaut 2. Enfin, dans ce cas, R11 et/ou R12 est alkyle inférieur.
Patent EP-1646722-A1 (EP)
Inventor: HAWKES TIMOTHY ROBERT
IPC: C12N15/82
Filed: 2004-06-09
Abstract: L'invention concerne un procédé de production de plantes stériles mâles ou femelles, qui consiste à prévoir des moyens d'inactivation d'un herbicide et des moyens de réactivation de l'herbicide ainsi inactivé. Les moyens d'inactivation de l'herbicide sont prévus dans les tissus végétatifs, et les moyens de réactivation dans les structures reproductrices mâles ou femelles de la plante, afin de protéger les structures végétatives, mais pas les structures reproductrices, contre l'activité phytotoxique de l'herbicide lorsque celui-ci est appliqué sur la plante.
Patent EP-1658263-A1 (EP)
Inventor: OTTOSEN ERIK RYTTER
IPC: C07C275/40
Filed: 2004-07-09
Abstract: The invention provides novel compounds according to formula I relates to compounds with the general formula I said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases or cancer.
Patent EP-1652202-A1 (EP)
Inventor: SALVINI HUBERTUS JOHANNES THEO
IPC: H01H71/00
Filed: 2004-08-09
Abstract: A pressure-operated switch for switching a connected assembly on and off comprises a spring dome (1), which contains a mechanical switching mechanism, and comprises an interrupter (9) that is actively connected to said spring dome. The invention is characterized by having a module (3) consisting of a device (6) for recognizing voltage and/or current of the load energy flow, of an evaluation unit (7) connected thereto, and of a switch for tripping the interrupter (9).
Patent EP-1648481-A1 (EP)
Inventor: COFFIN ROBERT STUART
IPC: A61P35/00
Filed: 2004-07-26
Abstract: The present invention provides a herpes virus which lacks a functional ICP34.5 encoding gene and which comprises two or more of—(i) a gene encoding a prodrug converting enzyme; (ii) a gene encoding a protein capable of causing cell to cell fusion; and (iii) a gene encoding an immunomodulatory protein.
Patent EP-1781149-A1 (EP)
Inventor: RANZONI FRANCESCO
IPC: A47J31/30
Filed: 2004-07-20
Abstract: Equipment for the preparation of a hot beverage comprising a boiler capable of containing a liquid component of the beverage, for example water, a collection container and means defining a delivery path for the liquid component from the boiler to the collection container. The equipment also comprises valve means located along the delivery path for the liquid component comprising a plug which can move between a position in which the delivery path is closed and one in which it is open and means to immobilise the plug in the open position. These means are arranged in such a way that they can be activated and deactivated by a force exerted in the direction of movement of the plug. The means for immobilising the plug comprise at least one pair of members capable of attracting each other through magnetic force.
Patent EP-1628596-A1 (EP)
Inventor: LEANNA GARY J
IPC: A61F2/90
Filed: 2004-05-24
Abstract: An open frame prosthesis (16) is formed with looped end terminations (34,36,38,33) at both ends. At one end of the prosthesis, the filaments or strands are welded together in pairs to form strand couplings (46). A plurality of loop segments are connected to the strand couplings, one loop segment for each pair of adjacent strand couplings. Strands at the opposite end are bent to form looped ends (33). The loop segments can be connected to the couplings by welding, fusion bonds, or tubes, which are either crimped or heat shrunk.
Patent EP-1658054-A1 (EP)
Title: Dosage form that is safeguarded from abuse
Inventor: BARTHOLOMAEUS JOHANNES
IPC: B29C48/40
Filed: 2004-08-05
Abstract: The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse and optionally physiologically acceptable adjuvants. The invention also relates to a corresponding method for producing said dosage form.
Patent EP-1663985-A1 (EP)
Inventor: CHOU DAVID TEH-WEI
IPC: C07D401/04
Filed: 2004-08-21
Abstract: La présente invention a trait à des dérivés d'alkylaminopyrazole substitués en position 5 de formule (I), dans laquelle les divers symboles sont tels que définis dans la description ou des sels de ceux-ci, à leurs procédés de préparation, à des compositions contenant lesdits dérivés, et à leur utilisation dans la lutte contre les animaux nuisibles (y compris des arthropodes et des helminthes).
Patent EP-1644100-A1 (EP)
Inventor: REGNIER PHILIPPE
IPC: B01D46/00
Filed: 2004-06-30
Abstract: The invention relates to an air filtration unit, comprising a filter cartridge (4) of the filtration bag (6) type, said bags (6) being arranged vertically and held extended by appropriate fixing means (16, 17), between two support structures (12, 13). The upper ends (15) of said bags (6) are fixed to an upper support structure (13), in the form of a perforated sheet and the lower ends thereof (14) are fixed to a lower support structure (12), in the form of a grille. According to the invention, the fixing means (16, 17), for the filtration bags (6), are embodied to permit the tensioning of said bags (6) at the upper end (15) thereof. The invention further relates to a particular method for assembly of a filtration bag within a unit as above, a tool for tensioning bags, embodied to be suitable for the said unit.
Patent EP-1661090-A1 (EP)
Inventor: HABETS RAYMOND J E
IPC: G06T7/00
Filed: 2004-08-18
Abstract: L'invention concerne un procédé s'utilisant dans un environnement médical et permettant d'élaborer un modèle exécutable d'un protocole de traitement d'images (21). Dans ce procédé, un utilisateur sélectionne et charge à l'étape 22 une image de référence sur laquelle il définit à l'étape 24 toutes les marques repères nécessaires conjointement avec les opérations de traitement d'images nécessaires, au moyen d'un éditeur de protocole interactif conçu pour fonctionner dans une macro de groupe de classes relationnelles géométriques. Les actions mises en oeuvre par l'utilisateur dans le but d'élaborer le modèle sont enregistrées sous forme de paramètres correspondants dans le protocole. Lors de l'achèvement de l'élaboration du modèle, celui-ci est testé à l'étape 26 et est mémorisé à l'étape 28. Un procédé (30) s'utilisant dans un environnement médical pour mettre en oeuvre un processus personnalisé de traitement d'images comporte les étapes consistant à charger un modèle choisi dans une liste de modèles prédéfinis (étape 32), à réaliser les opérations de personnalisation nécessaires (étape 33), et à exécuter le modèle (étape 36). Le protocole de traitement d'images invite l'utilisateur à définir les repères réels pour l'image réelle (étape 38), et crée la superposition graphique réelle sur l'image réelle (étape 40) lors de l'achèvement de la définition des repères. L'invention concerne également un dispositif, un programme informatique et un appareil d'examen médical permettant la mise en oeuvre des procédés ci-décrits.
Patent EP-1783189-A1 (EP)
Inventor: KITAZAWA DAISUKE
IPC: H05B33/14
Filed: 2004-08-23
Abstract: The invention provides a light emitting device having a low driving voltage and excellent durability by a material for a light emitting device expressed by the general formula (1) :
     
wherein each of R 1 , R 2 , R 3 , R 4 , R 5  and R 6  may be the same or different and is selected from hydrogen, an alkyl group, and an aryl group, A represents an n-valent aromatic hydrocarbon group, B represents an alkyl group or an aryl group, X represents carbon or nitrogen, n represents a natural number from 2 to 6, and n substituents having a phenanthroline skeleton or a benzoquinoline skeleton may be the same or different.
Patent EP-1677992-A1 (EP)
Inventor: DAGH INGEMAR
IPC: B60B7/06
Filed: 2004-10-12
Abstract: L'invention concerne un procédé permettant de monter des accessoires de jante sur un véhicule, ce dernier étant équipé de jantes (3) pourvues d'éléments de fixation permettant de fixer la jante sur un moyeu de roue. Les étapes de ce procédé consistent à: - assembler un support (6) composé d'au moins deux sections (7, 8), ce support comprenant au moins une première surface (18) de contact le long de son pourtour externe, destinée à venir s'appuyer contre une surface (17) de contact coopérante sur la périphérie interne de la jante, la surface de contact située à l'intérieur dans le sens radial étant sensiblement parallèle et adjacente au bord de la jante, situé à l'extérieur dans le sens axial; - monter le support en appliquant une force pour écarter les surfaces terminales adjacentes (11, 12; 13, 14) des sections du support, de manière à bloquer ainsi le support (6) sur la jante (3), - monter un accessoire sur le support (6), ce dernier comprenant au moins une seconde surface (15) de contact qui s'étend vers l'intérieur dans la direction radiale, le long de la périphérie interne de la jante, ladite seconde surface de contact étant pourvue d'au moins deux ouvertures (16) dans chaque section du support, destinées à coopérer avec au moins un nombre correspondant d'éléments de fixation (24, 30) présents sur ledit accessoire (23, 25, 26). L'invention concerne également un dispositif permettant le montage d'un tel accessoire, et un support destiné à cet usage.
Patent EP-1680222-A1 (EP)
Inventor: CHANG YUN-FENG
IPC: B01J29/83
Filed: 2004-06-17
Abstract: L'invention concerne une composition de catalyse à tamis moléculaire, un procédé de fabrication ou de formation de ladite composition de catalyse à tamis moléculaire, et un procédé de conversion dans lequel est utilisée la composition de catalyse. L'invention concerne, en particulier, la fabrication de ladite composition de catalyse à tamis moléculaire formulée à l'aide d'un tamis moléculaire synthétisé récupéré au moyen d'un floculant. La composition formulée est utilisée, en particulier, dans un processus de conversion de production d'oléfine(s), de préférence de l'éthylène et/ou du propylène, à partir d'une alimentation, de préférence une alimentation faite de composés oxygénés.
Patent EP-1670389-A1 (EP)
Title: Endoprothese comportant un revetement et un materiau actif sur le plan biologique
Inventor: LENSON MARK L
IPC: A61F2/06
Filed: 2004-08-13
Abstract: L'invention concerne un dispositif composite permettant de distribuer des agents bioactifs associés à celui-ci. Ce dispositif comprend un premier revêtement polymère (14) et un deuxième revêtement polymère (16) lié au premier revêtement. Ledit dispositif comprend en outre un élément structural intermédiaire (12) interposé entre les revêtements, défini par des segments solides et des ouvertures entre les segments solides. Les revêtements sont reliés par les ouvertures afin que soit formée au moins une poche autour des segments solides. Un agent bioactif (28) est situé au sein des segments solides de l'élément structural intermédiaire.
Patent EP-1688583-A1 (EP)
Inventor: IWASAKI SHINYA
IPC: E06B9/17
Filed: 2004-09-28
Abstract: A shutter curtain lifting prevention structure comprises a shutter curtain formed by connecting a plurality of slats via an interlock portion in the vertical direction, guide rails standing on both sides of an opening of the construction, and a cutout recess being integrally formed at the guide groove of each guide rail. The cutout recess is formed by horizontally cutting out the interior side plane portion of the front face located above and in the vicinity of the floor surface, such that when a bottom plate of the shutter curtain kept in a shut state is lifted, a connection portion of the bottom plate and the slat, which is opposed to the cutout recess is made engaged by the engaging portion defined by the cutout recess, thus preventing lifting of the shutter curtain.
Patent EP-1679487-A1 (EP)
Inventor: SUZUKI YUSUKE
IPC: H04W4/02
Filed: 2004-10-20
Abstract: A navigation device (100), which performs a route guidance, includes: a GPS unit (114) that acquires information about the current location by performing a communication with a global positioning system (GPS); a navigation-information acquiring unit (160) that acquires map data and route data from a navigation server (300) in a network (200); a guidance controller (120) that determines whether the information about the current location is acquired, and when the information is acquired, performs the route guidance based on the information; a GPS-communication controller (150) that cuts off the communication with the GPS when it is determined that the information about the current location is not acquired; and a server-communication controller (170) that cuts of a communication with the navigation server (300) when it is determined that the information about the current location is not acquired, thereby reducing power consumption and communication charges when the current location cannot be determined.
Patent EP-1742949-A1 (EP)
Title: Neue 2-(piperazin-1-yl)- und 2-(¬1,4|diazepan-1-yl)- imidazo¬4,5-d|pyridazin-4-one, deren herstellung und deren verwendung als arzneimittel  zur bekämpfung von diabetes mellitus
Inventor: HIMMELSBACH FRANK
IPC: C07D487/04
Filed: 2004-12-11
Abstract: Die vorliegende Erfindung betrifft substituierte Imidazo[4,5-d]pyridazin-4-one der allgemeinen Formel (I) in der R1 bis R3 und n wie in den Ansprüchen 1 bis 8 definiert sind, deren Tautomere, deren Enantiomere, deren Diastereomere, deren Gemische und deren Salze, welche wertvolle pharmakologische Eigenschaften aufweisen, insbesondere eine Hemmwirkung auf die Aktivität des Enzyms Dipeptidylpeptidase-IV (DPP-IV).